We are on a never-ending quest to advance genetic technology
asked if a virus could be used to target genetic disease. Researching this question cleared the path for historic advances in genetic medicine, and AskBio ls helping to lead the way.
Brain Case completed tens of millions of CNY in angel round financing time:.
Its viral vector tools can serve the fields of brain science, cell gene therapy, and oncolytic viruses. On August 20, 2022, Brain Case(Shenzhen) Biotechnology Co., Ltd. (hereinafter referred to as Blinkers) announced the completion of tens of millions